ftInvstr

VAISHALI · Healthcare ₹8.4 +0.24% Mkt Cap ₹109 Cr

VAISHALI

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹8.4

+0.24% today · 30d +6.33%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for VAISHALI. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2025-12-31

REVENUE

₹25 Cr

-11.69% YoY

NET PROFIT

₹1 Cr

-8.64% YoY

OPM

9.6%

+1.2pp YoY

EPS

₹0.1

PE 139.5

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-16.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

VAISHALI139.5—

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 5

Valuation STRETCHED 5

Growth STEADY 64

Profitability DECENT 55

Technicals STRONG 70

Risk LOW 80

Key Stats

TTM PE

139.5

P/B

1.58

52W HIGH

₹13.05

OFF HIGH

-35.63%

MKT CAP

₹109 Cr

◉ Active Signals

MACDBullish0.0001

RSI(14)Bullish60.47

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VAISHALI and at what entry.